Medical News

RSS

Regulus present advancements in microRNA platform at Oligonucleotide Therapeutics Society meeting

Regulus Therapeutics Inc. announced today that advancements from its leading microRNA platform and product pipeline were presented at the "6th Annual Meeting of the Oligonucleotide Therapeutics Society" held October 20 - 23, 2010 in Dana Point, California.

22 Oct 2010

LA. drops plans for quickly setting up new health plan for poor; national health insurer accused on providing "junk insurance" in Calif

In the face of mounting opposition, the Jindal administration dropped plans late Wednesday to expedite approval of rules needed to implement a new health-care delivery system for the poor.

22 Oct 2010

Neoprobe submits BLA response letter to FDA to commercialize RIGS technology

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has submitted a response letter to the U.S. Food and Drug Administration (FDA) regarding its RIGScan technology Biologic License Application (BLA).

22 Oct 2010

Rising cost of long-term care threatens state, federal budgets

The Fiscal Times reports on the surging costs of long-term care, "which amount to a fiscal time bomb for states and the federal government."

22 Oct 2010

Biogen, Genentech announce new structure of anti-CD20 collaboration

Biogen Idec and Genentech, Inc. a wholly owned member of the Roche Group today announced that they have agreed to amend their collaboration on antibodies targeting CD20.

22 Oct 2010

Clinical research scholar receives grant to promote lifestyle changes for HIV patients

Between the demands of work, family and friends, many women find health takes a back seat. Women with HIV are no exception. "Many women with the HIV face challenges from sleepless nights to little personal time-all activities that can negatively impact health," says Allison Webel, a clinical research scholar and instructor at the Frances Payne Bolton School of Nursing at Case Western Reserve University.

22 Oct 2010

Novartis releases study results on oral calcitonin for treatment of osteoarthritis: Unigene Laboratories

Unigene Laboratories, Inc. announced today that Novartis has released information on the first of two studies on oral calcitonin for the treatment of osteoarthritis conducted by its license partner Nordic Bioscience. The recently completed Study 2301, which assesses the safety and efficacy of oral calcitonin in the treatment of knee osteoarthritis, had three co-primary endpoints.

22 Oct 2010

Malaria deaths in India 13 times higher than WHO estimate, study says

"Malaria kills around 205,000 people in India each year, more than 13 times the estimate made by the World Health Organization, researchers said on Thursday," Reuters reports.

22 Oct 2010

Orthopaedic Surgeon implants first MIDLINE device at Valley Hospital

Just days after Centinel Spine's new STALIF MIDLINE Integrated Interbody Fusion system was unveiled at the annual meeting of the North American Spine Society (NASS), the first MIDLINE device has been successfully implanted by noted Orthopaedic Surgeon, John S. Thalgott, MD at Valley Hospital in Las Vegas, NV.

22 Oct 2010

Idera announces IMO-3100 Phase 1 clinical trial results for autoimmune disease

Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.

22 Oct 2010

State races take on health care tone as candidates talk overhaul

The health overhaul is making itself felt in political races around the country.

22 Oct 2010

Insurance commissioners to vote on spending requirements

The National Association of Insurance Commissioners will make a final vote on its recommendations for regulating how much insurers must spend on medical services, a key health law provision, Kaiser Health News reports.

22 Oct 2010

New findings shed light on how brain wires itself during first few years of life

A new paper from MIT neuroscientists, in collaboration with Alvaro Pascual-Leone at Beth Israel Deaconess Medical Center, offers evidence that it is easier to rewire the brain early in life. The researchers found that a small part of the brain's visual cortex that processes motion became reorganized only in the brains of subjects who had been born blind, not those who became blind later in life.

22 Oct 2010

Dicerna secures $4 million in second closing of Series B equity financing

Dicerna Pharmaceuticals, Inc. a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology and Dicer Substrate siRNA (DsiRNA) molecules, today announced a second closing of its Series B equity financing, securing an additional $4 million and bringing the total capital raised in this round to $29 million.

22 Oct 2010

Atherotech to present VAP Cholesterol Test at OMED 2010

Atherotech Diagnostics Lab will showcase its VAP Cholesterol Test in booth 324 at the American Osteopathic Association's 115th Annual Osteopathic Medical Conference & Exposition (OMED 2010). The gathering of DOs, residents, interns, students, researchers and health care professionals will be held October 24-28 at Moscone Convention Center in San Francisco.

22 Oct 2010

Advaxis completes patient recruitment in ADXS11-001 phase II study for cervical dysplasia

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, completes recruitment of the first group of patients in its US cervical dysplasia (CIN) phase II study of ADXS11-001 as required for the planned DMSB (safety board) meeting scheduled to be held January 11, 2011.

22 Oct 2010

Daiichi Sankyo launches Inavir inhalation powder in Japan

Hovione has been advised by Daiichi Sankyo Company Ltd that Inavir(R) has been launched in Japan. Inavir(R) is an inhalation powder which is delivered by the TwinCaps(R) inhaler to treat influenza. TwinCaps(R) was specifically designed by Hovione for this indication and is licensed to Daiichi Sankyo and to Biota Holdings Ltd.

22 Oct 2010

Celtic Pharma receives US patent for methods to treat breast, colon cancer

Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.

22 Oct 2010

Today's OpEds: Orszag on malpractice reform; debate over individual mandate; insurers' hard-ball tactics

Opponents of the act are generally off base in criticizing investments in improved care. In complaining about the missed opportunity to reform medical malpractice laws to promote evidence-based medical practice, on the other hand, the critics are entirely on target.

22 Oct 2010

Pinch of salt: How much is enough?

Salt restriction in the normal diet has come under debate. While scientists are questioning the complex role of sodium in the body and the need for salt restriction, surveys have found that dietary sodium has not gone down well in large populations despite awareness on the risks of too much salt intake.

21 Oct 2010

Medical News

Regulus present advancements in microRNA platform at Oligonucleotide Therapeutics Society meeting

LA. drops plans for quickly setting up new health plan for poor; national health insurer accused on providing "junk insurance" in Calif

Neoprobe submits BLA response letter to FDA to commercialize RIGS technology

Rising cost of long-term care threatens state, federal budgets

Biogen, Genentech announce new structure of anti-CD20 collaboration

Clinical research scholar receives grant to promote lifestyle changes for HIV patients

Novartis releases study results on oral calcitonin for treatment of osteoarthritis: Unigene Laboratories

Malaria deaths in India 13 times higher than WHO estimate, study says

Orthopaedic Surgeon implants first MIDLINE device at Valley Hospital

Idera announces IMO-3100 Phase 1 clinical trial results for autoimmune disease

State races take on health care tone as candidates talk overhaul

Insurance commissioners to vote on spending requirements

New findings shed light on how brain wires itself during first few years of life

Dicerna secures $4 million in second closing of Series B equity financing

Atherotech to present VAP Cholesterol Test at OMED 2010

Advaxis completes patient recruitment in ADXS11-001 phase II study for cervical dysplasia

Daiichi Sankyo launches Inavir inhalation powder in Japan

Celtic Pharma receives US patent for methods to treat breast, colon cancer

Today's OpEds: Orszag on malpractice reform; debate over individual mandate; insurers' hard-ball tactics

Pinch of salt: How much is enough?

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News